Aligos Therapeutics, Inc. (ALGS)
NASDAQ: ALGS · Real-Time Price · USD
4.690
+0.120 (2.63%)
Apr 17, 2025, 4:00 PM EDT - Market closed
Aligos Therapeutics Market Cap
Aligos Therapeutics has a market cap or net worth of $28.61 million as of April 17, 2025. Its market cap has decreased by -62.56% in one year.
Market Cap
28.61M
Enterprise Value
-19.95M
1-Year Change
-62.56%
Ranking
Category
Stock Price
$4.69
Market Cap Chart
Since the IPO on October 16, 2020, Aligos Therapeutics's market cap has decreased from $553.35M to $28.61M, a decrease of -94.83%. That is a compound annual growth rate of -48.19%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 17, 2025 | 28.61M | -80.65% |
| Dec 31, 2024 | 147.87M | 197.20% |
| Dec 29, 2023 | 49.75M | 21.95% |
| Dec 30, 2022 | 40.80M | -91.93% |
| Dec 31, 2021 | 505.85M | -52.00% |
| Dec 31, 2020 | 1.05B | 90.47% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 659.93B |
| UnitedHealth Group | 535.14B |
| Johnson & Johnson | 370.90B |
| AbbVie | 303.70B |
| Novo Nordisk | 284.50B |
| Abbott Laboratories | 224.94B |
| AstraZeneca | 210.38B |
| Novartis AG | 210.23B |